Capricor Stock Rallies 20% on DMD Data Presentation Update

Seeking AlphaOct 5 01:33

Wave Life Sciences Is Maintained at Sector Perform by RBC Capital

Dow JonesOct 4 23:48 · Ratings

RBC Raises Price Target on WAVE Life Sciences to $7 From $5, Keeps Sector Perform Rating, Speculative Risk

MT NewswiresOct 4 19:30 · Ratings

B.Riley Financial Maintains Wave Life Sciences(WVE.US) With Buy Rating, Raises Target Price to $19

Futu NewsOct 3 21:33 · Ratings

B. Riley Adjusts WAVE Life Sciences' PT to $19 From $11, Maintains Buy Rating

MT NewswiresOct 3 20:20

Better Biotech Stock: Wave Life Sciences Vs. Sarepta Therapeutics

Yahoo FinanceOct 3 20:15